92548-59-9Relevant articles and documents
Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A
Im, Eun-Ju,Lee, Chan-Hyeong,Moon, Pyong-Gon,Rangaswamy, Gunassekaran Gowri,Lee, Byungheon,Lee, Jae Man,Lee, Jae-Chul,Jee, Jun-Goo,Bae, Jong-Sup,Kwon, Taeg-Kyu,Kang, Keon-Wook,Jeong, Myeong-Seon,Lee, Joo-Eun,Jung, Hyun-Suk,Ro, Hyun-Joo,Jun, Sangmi,Kang, Wonku,Seo, Seung-Yong,Cho, Young-Eun,Song, Byoung-Joon,Baek, Moon-Chang
, (2019)
Inhibitors of the secretion of cancer exosomes, which promote cancer progression and metastasis, may not only accelerate exosome biology research but also offer therapeutic benefits for cancer patients. Here we identify sulfisoxazole (SFX) as an inhibitor